ROURKELA: Researchers of the biotechnology and medical engineering wing of the National Institute of Technology-Rourkela (NIT ...
Blueprint Medicines' strong pipeline and Ayvakit growth make it promising. Read why BPMC stock is rated "Hold" due to high ...
Allogenic Hematopoietic Cell Transplant in Hematological Malignancies: Controversies and Perspective
The Allogeneic Hematopoietic Stem Cell Transplantation (HSCT), since the experiments in rodents in the 50’s, has become a ...
Researchers at the National Institute of Technology Rourkela (NITR) have made a significant breakthrough in bone regeneration ...
Dr. Alain Elbaz has spent decades pushing the boundaries of orthopedic medicine through innovative, minimally invasive ...
Human extracellular matrices can be edited in their composition using the CRISPR/Cas9 system, leading to materials exhibiting tailored regenerative capacities.
Researchers have performed the first known transplant of sperm-producing stem cells in hopes of restoring fertility in a man ...
Researchers at the National Institute of Technology (NIT) Rourkela have developed a bioink made from natural materials to ...
The story of two-year-old Madlenka, who urgently needs a bone marrow donor for a rare illness, has moved many people across ...
Prof. Devendra Verma's team at NIT Rourkela have developed a groundbreaking bioink for efficient 3D bioprinting in bone ...
Denosumab-bnht is expected to launch in the US in June 2025 per an agreement with the reference product’s manufacturer, Amgen ...
A machine learning model generated by a team from the European Society for Blood and Marrow Transplantation (EBMT) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback